jump to navigation

D-Pharm Raises $10 Million Clal Biotechnology, Israel Healthcare Ventures & Pitango May 15, 2006

Posted by israelhealthcare in Drug Discovery.
add a comment

Biopharmaceutical Company D-Pharm has raised $10 million in a private round of financing. The round was led by Clal Biotechnology Industries, Israel Healthcare Ventures Pitango Venture Capital, and existing investors: Care Capital, Gemini, and Polar Communications.

“These resources will enable us to fund the further development of our main product, DP-b99 for acute stroke currently in Phase 2 clinical trials, as well as to complete pre-clinical development of our lead candidate for Alzheimer’s disease,” said Dr. Alexander Kozak, D-Pharm’s Founder, Chief Executive Officer and President.

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company’s offices, research and development laboratories and pilot manufacturing plant are located in the Kiryat Weizmann Science Park in Nes Ziona, Israel.